ORIGINAL RESEARCH
Published on 13 May 2025
Cost-effectiveness analysis of first-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma
doi 10.3389/fimmu.2025.1575627
- 621 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Checkpoint Immunotherapy: Reshaping the Landscape of Gastrointestinal Cancer Treatment
Checkpoint Immunotherapy: Reshaping the Landscape of Gastrointestinal Cancer Treatment
5,585
Total downloads
27k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 25 Apr 2025
In vivo RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancer
doi 10.3389/fimmu.2025.1549229
- 1,095 views
ORIGINAL RESEARCH
Published on 31 Mar 2025
Efficacy and safety of immune checkpoint inhibitors in advanced biliary tract cancer: a real-world study
doi 10.3389/fimmu.2025.1493234
- 1,107 views
STUDY PROTOCOL
Published on 25 Feb 2025
Nab-paclitaxel combined with cadonilimab (AK104) as second-line treatment for advanced gastric cancer: protocol for a phase II prospective, multicenter, single-arm clinical trial
doi 10.3389/fimmu.2025.1519545
- 1,849 views
- 1 citation
SYSTEMATIC REVIEW
Published on 27 Jan 2025
Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1523455
- 2,404 views
- 1 citation
CASE REPORT
Published on 08 Jan 2025
Hepatoid adenocarcinoma of the stomach with ideal response to neoadjuvant chemo-immunotherapy: a case report
doi 10.3389/fimmu.2024.1496342
- 986 views
BRIEF RESEARCH REPORT
Published on 17 Dec 2024
Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study
doi 10.3389/fimmu.2024.1456193
- 1,197 views
- 2 citations
ORIGINAL RESEARCH
Published on 07 Nov 2024
Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study
doi 10.3389/fimmu.2024.1463017
- 1,305 views
- 1 citation
ORIGINAL RESEARCH
Published on 24 Oct 2024
Analysis of the treatment efficacy and prognostic factors of PD-1/PD-L1 inhibitors for advanced gastric or gastroesophageal junction cancer: a multicenter, retrospective clinical study
doi 10.3389/fimmu.2024.1468342
- 1,894 views
- 1 citation
ORIGINAL RESEARCH
Published on 27 Sep 2024
Pathological response following neoadjuvant immunotherapy and imaging characteristics in dMMR/MSI-H locally advanced colorectal cancer
doi 10.3389/fimmu.2024.1466497
- 2,125 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore